Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TPCN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC102725383 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
CLSTN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GIT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAF7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LPCAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ARHGAP31 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HYI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CISH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BAD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XAB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DOK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBMS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PGAM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on